Anastrozole is a medication used to treat breast cancer in postmenopausal women [1]. It belongs to a class of drugs called aromatase inhibitors, which work by reducing the amount of estrogen the body produces [1].
How does anastrozole work?
Anastrozole functions by blocking the action of an enzyme called aromatase. In postmenopausal women, aromatase is responsible for converting androgens into estrogen in peripheral tissues. By inhibiting aromatase, anastrozole significantly lowers circulating estrogen levels. Many breast cancers are estrogen-receptor-positive (ER+), meaning estrogen fuels their growth. Reducing estrogen can therefore slow or stop the growth of these cancers [1].
What types of breast cancer is anastrozole used for?
Anastrozole is primarily prescribed for the treatment of hormone receptor-positive, early-stage breast cancer in postmenopausal women [1]. It can also be used for advanced or metastatic breast cancer in this patient population [1].
When does anastrozole's patent exclusivity expire?
Patent exclusivity for anastrozole has expired, leading to the availability of generic versions [2]. This has significantly impacted its pricing and market availability.
Who manufactures generic anastrozole?
Multiple pharmaceutical companies now produce generic versions of anastrozole. This increased competition is a direct result of patent expirations [2].
What are the risks and side effects associated with anastrozole?
Common side effects of anastrozole include hot flashes, joint pain, muscle pain, fatigue, nausea, and vaginal dryness [1]. More serious, though less common, risks can include bone thinning (osteoporosis) and an increased risk of fractures [1]. Patients with a history of heart disease or blood clots should discuss these risks with their doctor before starting anastrozole [1].
How does anastrozole compare to other breast cancer treatments?
Anastrozole is often used as an alternative to tamoxifen, another common breast cancer medication. While both treat ER+ breast cancer, they work through different mechanisms and have distinct side effect profiles. Aromatase inhibitors like anastrozole are generally considered more effective than tamoxifen in preventing breast cancer recurrence in postmenopausal women, particularly for early-stage disease [3]. However, tamoxifen may be preferred for premenopausal women or those with specific risk factors [3].
What is the typical dosage and administration of anastrozole?
The standard dose of anastrozole is one milligram (1 mg) taken by mouth once a day [1]. It can be taken with or without food [1]. The duration of treatment is typically determined by a healthcare provider based on the individual patient's condition and response to therapy [1].
Are there alternatives to anastrozole for breast cancer?
Yes, alternatives to anastrozole include other aromatase inhibitors like letrozole and exemestane, as well as tamoxifen [3]. The choice of treatment depends on factors such as menopausal status, breast cancer stage, receptor status, and individual patient characteristics and risk tolerance [3].
What clinical data supports the use of anastrozole?
Large clinical trials, such as the Anastrozole, Tamoxifen, and Combination Therapy (ATAC) trial, have demonstrated the efficacy of anastrozole in reducing the risk of breast cancer recurrence compared to tamoxifen in postmenopausal women with early-stage breast cancer [4].
---
Sources:
[1] DrugPatentWatch.com
[2] DrugPatentWatch.com
[3] DrugPatentWatch.com
[4] DrugPatentWatch.com